Keigo Amari

发表

The CDK4/6-UCHL5-BRD4 axis confers resistance to BET inhibitors in MLL-rearranged leukemia cells by suppressing BRD4 protein degradation.

T. Imamura, S. Sasagawa, E. Ashihara, 2021, Biochemical and biophysical research communications.